Coherent Ventures

www.coherentcap.com

VCMatch tracks Coherent Ventures as an investor focused on Healthtech, Biotech, and Medtech companies, Pre-Seed and Seed rounds, and Global, United States, and United Kingdom markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A, Series B

Focus Areas

Healthtech, Biotech, Medtech

Geography

Global, United States, and United Kingdom

Investment Thesis

Coherent Capital positions fundraising as a strategic lever to create long-term value rather than a one-time capital event. They emphasize assembling the “right investors at the right time” to create downstream benefits for startups, and use their network and operational resources to turn fundraising into lasting strategic partnerships and market traction. The firm acts as a facilitator between startups and early- to mid-stage investors, combining investor-relations expertise with go-to-market and product resources to accelerate company growth.

Is Coherent Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Coherent Ventures is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Healthtech, Biotech, Medtech, and AI/ML, especially across Global, United States, and United Kingdom.

Focus statement

They focus on facilitating strategic investor relationships for promising, disruptive startups with a stated emphasis on healthtech and biohacking investments, and target early- to mid-stage companies that benefit from curated investor introductions and operational support.

Value Add

Explicit positioning of fundraising as a value-creation process: “we focus on leveraging the fundraising process to build long-term value for clients”
Specialized vertical focus and branding: repeated tags such as “Leaders in Biohacking, CPG & HealthTech” and a dedicated “Biohacking Investment Pitch (and Panel)” event
Operational and go-to-market resources in-house or via network: “Channel Sales Experts,” “International Accelerators,” “Software Development Resources,” and “Hardware & Manufacturing Expertise”
Talent and investor network claims: “Top 1% Talent Recruiting” and a global network of active early- to mid-stage investors built by team members
Subject-matter credibility on team: Wesley King described as the “Biohacking Investment Banker” with Series 7/63/79 licenses and Stephen Meyer with “20+ years of experience” and multiple exits
Event-driven deal flow and community access — running dedicated meetups/panels that bring VCs, funds, and corporates together (example: the June 25 Biohacking/HealthTech meetup)